Preclinical evaluation of implantable cardioverter-defibrillator developed for magnetic resonance imaging use

Heart Rhythm

Volumn 12, Issue 3, 2015, Pages 631-638

  Gold, Michael R ^a   Kanal, Emanuel ^b   Schwitter, Juerg ^c   Sommer, Torsten ^d   Yoon, Hyun ^e   Ellingson, Michael ^e   Landborg, Lynn ^e   Bratten, Tara ^e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d German Red Cross Hospital   (Germany)

^e MEDTRONIC INC   (United States)

Author keywords

Defibrillator; Hazards; Implantablecardioverter defibrillator; Leadelectrodeheating; Magneticresonanceimaging; Ventricular fibrillationdetection

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOG; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION EXPOSURE; SWINE; WHOLE BODY MRI; ADVERSE EFFECTS; ANIMAL; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR DISEASES; DEVICE SAFETY; DEVICES; EVALUATION STUDY; HUMAN; PROCEDURES; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; VENTRICULAR FIBRILLATION;

ANIMALS; CARDIOVASCULAR DISEASES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL; REPRODUCIBILITY OF RESULTS; VENTRICULAR FIBRILLATION;

EID: 84924193028     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.12.012     Document Type: Article

References (22)

1. 2012 MR Benchmark Report. IMV Medical Information Division, Inc.
2. Kaiser CP. Soaring MRI use draws scrutiny. Diagnostic Imaging Online January 4, 2002. Available at: http://www.diagnosticimaging.com/dimag/legacy/db-area/onlinenews/2002/2002010401.shtml. Accessed March 20, 2014.
3. R. Kalin, and M.S. Stanton Current clinical issues for MRI scanning of pacemaker and defibrillator patients Pacing Clin Electrophysiol 28 2005 326 328
4. R. Gimbel, D. Bello, M. Schmitt, B. Merkely, J. Schwitter, D. Hayes, T. Sommer, E. Schloss, Y. Chang, S. Willey, and E. Kanal Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla Heart Rhythm 10 2013 685 691
5. B.L. Wilkoff, D. Bello, and M. Taborsky Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment Heart Rhythm 8 2011 65 73
6. E. Kanal, A.J. Barkovich, and C. Bell ACR guidance document on safe MR practices J Magn Reson Imaging 37 2013 501 530
7. R. Luechinger, F. Duru, V. Zeijlemaker, M.B. Scheidegger, P. Boesiger, and R. Candinas Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysioj 25 2002 1419 1423
8. B.L. Wilkoff, T. Albert, M. Lazebnik, S.M. Park, J. Edmonson, B. Herberg, J. Golnitz, S. Wixon, J. Peltier, H. Yoon, S. Willey, and Y. Safriel Safe magnetic resonance imaging scanning of patients with cardiac rhythm devices: a role for computer modeling Heart Rhythm 10 2013 1815 1821
9. Assessment of the safety of magnetic resonance imaging for patients with an active implantable medical device. International Organization for Standardization, Geneva, Switzerland. ISO/TS10974:2012.
10. M.M. Swindle, A. Makin, A.J. Herron, F.J. Clubb Jr, and K.S. Frazier Swine as models in biomedical research and toxicology testing Vet Pathol 49 2012 344 356
11. ASTM Standard F2052, 2006e1. Standard test method for measurement of magnetically induced displacement force on medical devices in the magnetic resonance environment. West Conshohocken, PA: ASTM International; 2006.
12. ASTM Standard F2213, 2006 (2011). Standard test method for measurement of magnetically induced torque on medical devices in the magnetic resonance environment. West Conshohocken, PA: ASTM International; 2006.
13. L. Wexler, D.H. Bergel, I.T. Gabe, G.S. Makin, and C.J. Mills Velocity of blood flow in normal human venae cavae Circ Res 23 1968 349 359
14. P.A. Mackowiak, and J.A. Bouland Fever's glass ceiling Clin Infect Dis 22 1996 525 536
15. P.S. Yarmolenko, E.J. Moon, C. Landon, A. Manzoor, D.W. Hochman, B.L. Viglianti, and M.W. Dewhirst Thresholds for thermal damage to normal tissues: an update Int J Hyperthermia 27 2011 320 343
16. M. Fiek, T. Remp, C. Reithmann, and G. Steinbeck Complete loss of ICD programmability after magnetic resonance imaging Pacing Clin Electrophysiol 27 2004 1002 1004
17. A. Roguin, M. Zviman Menekhem, and R. Halperin Henry Re: complete loss of ICD programmability after magnetic resonance imaging Pacing Clin Electrophysiol 28 2005 354
18. C. Wollmann, M. Grude, B. Tombach, H. Kugel, W. Heindel, G. Breithardt, D. Böcker, and C. Vahlhaus Safe performance of magnetic resonance imaging on a patient with an ICD Pacing Clin Electrophysiol 28 2005 339 342
19. A. Roguin, J.K. Donahue, C.S. Bomma, D.A. Bluemke, and H.R. Halperin Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator Pacing Clin Electrophysiol 28 2005 336 338
20. S. Nazarian, R. Hanzford, and A. Roguin A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices Ann Intern Med 155 2011 415 424
21. J.D. Cohen, H.S. Costa, and R.J. Russo 1.5 Tesla for patients with pacemakers and implantable cardiac defibrillators Am J Cardiol 10 2012 1631 1636
22. Russo RJ, Costa H, Daud D. Determining the risks of MRI at 1.5 Tesla in patients with pacemakers and ICDs: the MagnaSafe Registry. Presented at the 2014 American Heart Association Annual Scientific Sessions. Nov. 15-19, 2014, Chicago, IL.